Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments

Nat Commun. 2022 Aug 2;13(1):4495. doi: 10.1038/s41467-022-32066-w.

Abstract

While hypoxia promotes carcinogenesis, tumour aggressiveness, metastasis, and resistance to oncological treatments, the impacts of hyperoxia on tumours are rarely explored because providing a long-lasting oxygen supply in vivo is a major challenge. Herein, we construct micro oxygen factories, namely, photosynthesis microcapsules (PMCs), by encapsulation of acquired cyanobacteria and upconversion nanoparticles in alginate microcapsules. This system enables a long-lasting oxygen supply through the conversion of external radiation into red-wavelength emissions for photosynthesis in cyanobacteria. PMC treatment suppresses the NF-kB pathway, HIF-1α production and cancer cell proliferation. Hyperoxic microenvironment created by an in vivo PMC implant inhibits hepatocarcinoma growth and metastasis and has synergistic effects together with anti-PD-1 in breast cancer. The engineering oxygen factories offer potential for tumour biology studies in hyperoxic microenvironments and inspire the exploration of oncological treatments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms*
  • Capsules
  • Cell Hypoxia
  • Disease Progression
  • Female
  • Humans
  • Hyperoxia*
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Oxygen
  • Tumor Microenvironment

Substances

  • Capsules
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Oxygen